TOP-389 Anti-GARP reverts immune suppression and extends overall survival in a MASH-HCC murine model resistant to anti-PDL1+anti-VEGFA therapy

Julia Huguet-Pradell; D. Camell-Raventós; Elisa Fernández-Martínez; Anthony Lozano; Tiago de Castro; Marcus Zeitlhoefler; Ugne Balaseviciute; Albert Gris‐Oliver; Daniela Sia; Roser Pinyol; Josep M. Llovet

doi:10.1016/s0168-8278(26)01346-2

Back

TOP-389 Anti-GARP reverts immune suppression and extends overall survival in a MASH-HCC murine model resistant to anti-PDL1+anti-VEGFA therapy

Article 2026 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2026

Abstract LB154: Anti-GARP reverts immune suppression and extends overall survival in a MASH-HCC murine model resistant to anti-PDL1+anti-VEGFA therapy

Julia Huguet-Pradell, D. Camell-Raventós, Elisa Fernández-Martínez, Anthony Lozano, Tiago de Castro, Marcus Zeitlhoefler, Ugne Balaseviciute, Albert Gris‐Oliver, D Sia, Roser Pinyol, Josep M. Llovet

Article2007

Photodynamic therapy stimulates anti-tumor immunity in a murine model

Paweł Mróz, Ana P. Castaño, Mei X. Wu, Andrew L. Kung, Michael R Hamblin

Article2008

Photodynamic therapy stimulates anti-tumor immunity in a murine mastocytoma model

Paweł Mróz, Michael R Hamblin

Article2005

Anti-tumor immunity generated by photodynamic therapy in a metastatic murine tumor model

Ana P. Castaño, Michael R Hamblin

Article2025

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial

George Lau, Bruno Sangro, Ann‐Lii Cheng, Masatoshi Kudo, Robin Kate Kelley, Won Young Tak, Antonio Gasbarrini, María Reig, Ho Yeong Lim, David Tougeron, Enrico N. De Toni, Vincent C. Tam, Kabir Mody, Jun Gong, Oxana Crysler, Wattana Sukeepaisarnjaroen, Oleg Lipatov, Manabu Morimoto, Isabelle Archambeaud, Valentina Burgio, Le Thi Tuyet Phuong,